<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02844803</url>
  </required_header>
  <id_info>
    <org_study_id>S.baicalensis-Metformin</org_study_id>
    <nct_id>NCT02844803</nct_id>
  </id_info>
  <brief_title>Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients</brief_title>
  <official_title>Pilot Study to Investigate the Effect of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Namyi Gu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DongGuk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a pilot trial to investigate the effect of Metformin and S. Baicalensis
      Combination Therapy in Type 2 Diabetes Mellitus Patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of serum glucose level after 8 weeks from baseline</measure>
    <time_frame>Day1 and Day 57 on the 1st and 2nd periods</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Active drug-&gt; Placebo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Metformin + S. Baicalensis --&gt; Metformin + Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo -&gt; Active drug</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Metformin + Placebo --&gt; Metformin + S. Baicalensis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combination of Metformin + S. Baicalensis</intervention_name>
    <description>the combination therapy for 8 weeks</description>
    <arm_group_label>Active drug-&gt; Placebo</arm_group_label>
    <arm_group_label>Placebo -&gt; Active drug</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combination of Metformin + Placebo</intervention_name>
    <description>the metformin single therapy for 8 weeks</description>
    <arm_group_label>Active drug-&gt; Placebo</arm_group_label>
    <arm_group_label>Placebo -&gt; Active drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed as a diabetes mellitus patient at least 3 months ago on screening

          -  Treated with metformin of â‰¥ 500 mg/day over 3 months on screening

          -  Fasting glucose level of 110~180 mg/dl or HbA1c of 7.0~9.0% on screening

        Exclusion Criteria:

          -  With acute or chronic inflammation

          -  Treated with systemic corticosteroids within 4 weeks prior to the first administration
             of study medication

          -  With heart failure, myocardial infarction, stroke, or other acute severe
             cardiovascular diseases

          -  With acute or chronic renal failure or nephrotic syndrome

          -  With impaired hepatic function.

          -  Drug or Alcoholic abuser

          -  Pregnant or nursing woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han Seok Choi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dongguk University College of Medicine and Ilsan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Namyi Gu, MD, PhD</last_name>
    <phone>+82-31-961-8440</phone>
    <email>namyi.gu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Han Seok Choi, MD, PhD</last_name>
    <phone>+82-31-961-5777</phone>
    <email>hschoi402@dumc.or.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dongguk University Ilsan Hospital</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <zip>410-773</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Namyi Gu, MD, PhD</last_name>
      <phone>+82-31-961-8440</phone>
      <email>namyi.gu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2016</study_first_submitted>
  <study_first_submitted_qc>July 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2016</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>DongGuk University</investigator_affiliation>
    <investigator_full_name>Namyi Gu</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

